146 related articles for article (PubMed ID: 32983071)
41. Antimicrobial Properties of Gallium(III)- and Iron(III)-Loaded Polysaccharides Affecting the Growth of
Best MG; Cunha-Reis C; Ganin AY; Sousa A; Johnston J; Oliveira AL; Smith DGE; Yiu HHP; Cooper IR
ACS Appl Bio Mater; 2020 Nov; 3(11):7589-7597. PubMed ID: 35019499
[TBL] [Abstract][Full Text] [Related]
42. Chlorate Specifically Targets Oxidant-Starved, Antibiotic-Tolerant Populations of Pseudomonas aeruginosa Biofilms.
Spero MA; Newman DK
mBio; 2018 Sep; 9(5):. PubMed ID: 30254119
[TBL] [Abstract][Full Text] [Related]
43. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
44. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
Müsken M; Pawar V; Schwebs T; Bähre H; Felgner S; Weiss S; Häussler S
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297365
[TBL] [Abstract][Full Text] [Related]
45. Gum arabic capped-silver nanoparticles inhibit biofilm formation by multi-drug resistant strains of Pseudomonas aeruginosa.
Ansari MA; Khan HM; Khan AA; Cameotra SS; Saquib Q; Musarrat J
J Basic Microbiol; 2014 Jul; 54(7):688-99. PubMed ID: 24403133
[TBL] [Abstract][Full Text] [Related]
46. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial activity and effectiveness of a combination of sodium hypochlorite and hydrogen peroxide in killing and removing Pseudomonas aeruginosa biofilms from surfaces.
DeQueiroz GA; Day DF
J Appl Microbiol; 2007 Oct; 103(4):794-802. PubMed ID: 17897181
[TBL] [Abstract][Full Text] [Related]
48. Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum.
Bonchi C; Frangipani E; Imperi F; Visca P
Antimicrob Agents Chemother; 2015 Sep; 59(9):5641-6. PubMed ID: 26149986
[TBL] [Abstract][Full Text] [Related]
49. Nitric Oxide and Iron Signaling Cues Have Opposing Effects on Biofilm Development in Pseudomonas aeruginosa.
Zhu X; Rice SA; Barraud N
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478229
[TBL] [Abstract][Full Text] [Related]
50. Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions.
O'May CY; Sanderson K; Roddam LF; Kirov SM; Reid DW
J Med Microbiol; 2009 Jun; 58(Pt 6):765-773. PubMed ID: 19429753
[TBL] [Abstract][Full Text] [Related]
51. Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms.
Beaudoin T; Stone TA; Glibowicka M; Adams C; Yau Y; Ahmadi S; Bear CE; Grasemann H; Waters V; Deber CM
Sci Rep; 2018 Oct; 8(1):14728. PubMed ID: 30283025
[TBL] [Abstract][Full Text] [Related]
52. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm.
Banin E; Brady KM; Greenberg EP
Appl Environ Microbiol; 2006 Mar; 72(3):2064-9. PubMed ID: 16517655
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles.
García-Lara B; Saucedo-Mora MÁ; Roldán-Sánchez JA; Pérez-Eretza B; Ramasamy M; Lee J; Coria-Jimenez R; Tapia M; Varela-Guerrero V; García-Contreras R
Lett Appl Microbiol; 2015 Sep; 61(3):299-305. PubMed ID: 26084709
[TBL] [Abstract][Full Text] [Related]
54. Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum.
Crabbé A; Liu Y; Matthijs N; Rigole P; De La Fuente-Nùñez C; Davis R; Ledesma MA; Sarker S; Van Houdt R; Hancock RE; Coenye T; Nickerson CA
Sci Rep; 2017 Mar; 7():43321. PubMed ID: 28256611
[TBL] [Abstract][Full Text] [Related]
55. Furoxan Nitric Oxide Donors Disperse Pseudomonas aeruginosa Biofilms, Accelerate Growth, and Repress Pyoverdine Production.
Poh WH; Barraud N; Guglielmo S; Lazzarato L; Rolando B; Fruttero R; Rice SA
ACS Chem Biol; 2017 Aug; 12(8):2097-2106. PubMed ID: 28628310
[TBL] [Abstract][Full Text] [Related]
56. Nitric oxide-releasing polyacrylonitrile disperses biofilms formed by wound-relevant pathogenic bacteria.
Craven M; Kasper SH; Canfield MJ; Diaz-Morales RR; Hrabie JA; Cady NC; Strickland AD
J Appl Microbiol; 2016 Apr; 120(4):1085-99. PubMed ID: 26784529
[TBL] [Abstract][Full Text] [Related]
57. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
58.
Tan JH; Vidaillac C; Yam JKH; Chua SL; Givskov M; Yang L
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461320
[TBL] [Abstract][Full Text] [Related]
59. Gallium(iii) and iron(iii) complexes of quinolone antimicrobials.
Mjos KD; Cawthray JF; Polishchuk E; Abrams MJ; Orvig C
Dalton Trans; 2016 Aug; 45(33):13146-60. PubMed ID: 27315225
[TBL] [Abstract][Full Text] [Related]
60. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
Kolpen M; Appeldorff CF; Brandt S; Mousavi N; Kragh KN; Aydogan S; Uppal HA; Bjarnsholt T; Ciofu O; Høiby N; Jensen PØ
Pathog Dis; 2016 Feb; 74(1):ftv086. PubMed ID: 26458402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
